Zobrazeno 1 - 10
of 11
pro vyhledávání: '"CXCL, CXC chemokine ligand"'
Autor:
Xiaohui Pan, Bo Yang, Hongjie Guo, Shuyuan Cheng, Xi Chen, Ling Ding, Qiaojun He, Wenxin Zhang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 5, Pp 723-733 (2020)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Immunotherapy strategies targeting the programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) pathway in clinical treatments have achieved remarkable success in treating multiple types of cancer. However, owing to the heterogeneity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ca7b0479f6fea7a89a3e1eb06905c5
https://doi.org/10.1016/j.apsb.2019.09.006
https://doi.org/10.1016/j.apsb.2019.09.006
Autor:
Tomalika Rahmat Ullah
Publikováno v:
Journal of Bone Oncology
Journal of Bone Oncology, Vol 17, Iss, Pp-(2019)
Journal of Bone Oncology, Vol 17, Iss, Pp-(2019)
CXCR4 is a pleiotropic chemokine receptor which acts through its ligand CXCL12 to regulate diverse physiological processes. CXCR4/CXCL12 axis plays a pivotal role in proliferation, invasion, dissemination and drug resistance in multiple myeloma (MM).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2aef32d7c524945afc1fdd274518216
http://europepmc.org/articles/PMC6658931
http://europepmc.org/articles/PMC6658931
Autor:
Takanori, Kitamura, Jeffrey W, Pollard
Publikováno v:
Pharmacological Research
Graphical abstract Tumor-infiltrang immune cells such as metastasis-associated macrophages (MAM), regulatory T (Tregreg) cells, and myeloid-derived suppressor cells (MDSC) are reported to promote establishment of the lethal metasta-c foci and restric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f86d500246f37ab68b124a812754209
https://pubmed.ncbi.nlm.nih.gov/26275794
https://pubmed.ncbi.nlm.nih.gov/26275794
Autor:
Elena Geretti, Heide Potzinger, Andreas J. Kungl, Angelika Falsone, Veronica Wabitsch, Tanja Gerlza, Mauro M. Teixeira, James Robinson, Tiziana Adage
Publikováno v:
Bioscience Reports
IL (interleukin)-8 [CXCL8 (CXC chemokine ligand 8)] exerts its role in inflammation by triggering neutrophils via its specific GPCRs (G-protein-coupled receptors), CXCR1 (CXC chemokine receptor 1) and CXCR2, for which additional binding to endothelia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2770eb8dbf36e325b6e7fcb836160352
https://doi.org/10.1042/bsr20130069
https://doi.org/10.1042/bsr20130069
Autor:
Sunita Appikatla, Ajaib S. Paintlia, Carrie L Tatar, Denise Bessert, Inderjit Singh, Robert P. Skoff
Publikováno v:
ASN NEURO
PMD (Pelizaeus-Merzbacher disease) is a rare neurodegenerative disorder that impairs motor and cognitive functions and is associated with a shortened lifespan. The cause of PMD is mutations of the PLP1 [proteolipid protein 1 gene (human)] gene. Trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0551f435b30e52869025b9ef0ef05fd5
https://pubmed.ncbi.nlm.nih.gov/20885931
https://pubmed.ncbi.nlm.nih.gov/20885931
Autor:
Liu X; Center for Precision Medicine and Division of Cardiovascular Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA.; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA., Jiang B; Department of Pathophysiology, Central South University, Changsha, China., Hao H; Center for Precision Medicine and Division of Cardiovascular Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA., Liu Z; Center for Precision Medicine and Division of Cardiovascular Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri, USA.
Publikováno v:
JACC. Basic to translational science [JACC Basic Transl Sci] 2022 Apr 25; Vol. 7 (4), pp. 406-409. Date of Electronic Publication: 2022 Apr 25 (Print Publication: 2022).
Autor:
Jafari M; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Kolahdooz H; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Mahmoudi M; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Azarnaminy AF; Department of Anesthesiology, Social Security Organization Hospital, Ardabil, Iran., Mobasheri L; Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Esmaeili SA; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Publikováno v:
Gene reports [Gene Rep] 2022 Mar; Vol. 26, pp. 101503. Date of Electronic Publication: 2022 Jan 15.
Autor:
Chen X; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Pan X; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Zhang W; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Guo H; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Cheng S; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., He Q; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Yang B; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China., Ding L; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2020 May; Vol. 10 (5), pp. 723-733. Date of Electronic Publication: 2019 Sep 25.
Autor:
Ullah TR; Hudson Institute of Medical Research, 27-31 wright street, Clayton VIC 3168, Australia.
Publikováno v:
Journal of bone oncology [J Bone Oncol] 2019 Jul 16; Vol. 17, pp. 100253. Date of Electronic Publication: 2019 Jul 16 (Print Publication: 2019).
Autor:
Gommerman JL; a Department of Immunology ; University of Toronto ; Toronto , ON Canada., Rojas OL, Fritz JH
Publikováno v:
Gut microbes [Gut Microbes] 2014; Vol. 5 (5), pp. 652-62.